secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001437749-24-020534
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix names Brad Hauser CEO; grants 900k-share inducement option; Bisson becomes Vice Chair
--------------------------------------------------------------------------------

- Brad Hauser appointed CEO and President; base salary $450,000, target bonus 60%.
- Hauser receives 10-year option for 900,000 shares at closing price on June 17, vesting over 4 years.
- Lori Bisson steps down as CEO, appointed Executive Vice Chair and Strategic Adviser; base salary $150,000, target bonus 50%.
- Bisson continues vesting in prior options and forfeits severance in connection with the role change.
- Inducement options granted outside 2023 Stock Plan per Nasdaq Listing Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924020534/0001437749-24-020534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924020534/amix20240615_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-020534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer